In this article the authors retrospectively reviewed data obtained from December 20, 2020, to May 31, 2021, regarding all cases of myocarditis and categorized the information using the Brighton Collaboration definition.

In this article the authors searched the database of Clalit Health Services, the largest health care organization (HCO) in Israel, for diagnoses of myocarditis in patients who had received at least one dose of the BNT162b2 mRNA vaccine (Pfizer–BioNTech).

Study of data from the Israeli Ministry of Health database regarding 1,137,804 persons who were 60 years of age or older and had been fully vaccinated at least 5 months earlier.

The authors investigated the safety, vaccine efficacy, and immunogenicity of two doses of AZD1222 as compared with placebo in preventing the onset of symptomatic and severe COVID-19 15 days or more after the second dose in adults.

In this article the authors used a matched test-negative, case–control study design to estimate vaccine effectiveness against any SARS-CoV-2 infection and against any severe, critical, or fatal case of COVID-19, from January 1 to September 5, 2021.

In this article the authors conducted a 6-month longitudinal prospective study involving vaccinated health care workers who were tested monthly for the presence of anti-spike IgG and neutralizing antibodies.

Our research paper of the month is a retrospective cohort study, aiming to investigate the association between field position, professional career length and playing era and increased risk of neurodegenerative disease among male former professional soccer players.

The aim of this study was to describe neurological and psychiatric complications of infection with SARS CoV 2 in children and adolescents and determine the prevalence of such manifestations in hospitalised patients under 18 years-old.

This patient-led online research study enrolled 3762 participants with confirmed or suspected COVID-19, 93.2% of whom were experiencing symptoms after 28 days, referred as ‘Long COVID’.

The Stroke Research Center Bern is conducting a survey on covert brain infarction, to gather information on current practice and attitudes towards covert brain infarctions from medical practitioners who encounter them in their daily work.

The European Brain Council will host an online event on the subject of 'Best practices for patient safety: An EU-wide view on the use of medicines off-label' on 30 November at 14:30 (CET).

The European Academy of Neurology and the European Alzheimer's Disease Consortium hold a joint session on Wednesday, 1 December, 2021.

Free EAN-BRAINS workshop taking place on 9-11 December.

Alzheimer Europe has published a new edition of its Dementia in Europe policy magazine, in an electronic format.

EAN has endorsed the ESRS's Sleep Medicine Texbook (2nd ed.) which is available to EAN members at the ESRS member price.